Page 6 - Jerome Boyd Kirkup News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Hummingbird Bioscience Announces UK MHRA Approval For First-in-Human Phase 1 Trial Of HMBD-001 In Advanced Cancers
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Business Scoop » Hummingbird Bioscience Announces UK MHRA Approval For First-in-Human Phase 1 Trial Of HMBD-001 In Advanced Cancers
scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Hummingbird Bioscience and MD Anderson Announce Strategic Research Collaboration To Advance Innovative Immunotherapies
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
MD Anderson and Hummingbird Bioscience announce strategic research collaboration to advance innovative immunotherapies
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
SG biotech startup Hummingbird Bioscience bags $125m Series C funding
Antibody visual sourced from Hummingbird s website
May 18, 2021
Singapore-based biotech startup Hummingbird Bioscience has announced raising $125 million in a Series C funding round led by life science investor Novo Holdings.
A syndicate of international biotech investors also participated in the funding round, including Frazier Healthcare Partners, Octagon Capital, EDBI, AMGEN Ventures, and existing investors SK Inc, Heritas Capital, and Mirae Asset Venture Capital, and others.
The biotech startup, which raised $25 million in an extended Series B round in May 2020, said it will use the fresh funding to advance the clinical development of its lead assets, including the antibody HMBD-001, which targets HER3, a cell surface protein associated with several cancers, including colorectal, gastric, and lung.